Ignite Creation Date:
2024-05-06 @ 12:06 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01488071
Status:
COMPLETED
Last Update Posted:
2014-03-26
First Post:
2011-11-29
Brief Title:
A Study of Vortioxetine Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication
Sponsor:
H Lundbeck AS
Organization:
H Lundbeck AS
Study Overview
Official Title:
A Randomised Double-blind Parallel-group Active-controlled Flexible Dose Study Evaluating the Effects of Vortioxetine Lu AA21004 Versus Agomelatine in Adult Patients Suffering From Major Depressive Disorder With Inadequate Response to Antidepressant Treatment
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REVIVE
Brief Summary:
The objective of the present study is to evaluate whether vortioxetine 10 or 20 mgday is at least as effective as agomelatine 25 to 50 mgday in patients with depressive symptoms that showed inadequate response to Serotonin Reuptake Inhibitors SRI antidepressants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2011-002362-21 | EUDRACT_NUMBER | None | None |